Dr. Ravinder K. Wali, MD

Dr. Wali practices at Umass Memorial Medical Center in Mendon, Massachusetts.

Dr. Wali's NPI, 1821030933, was assigned on June 12, 2006. Dr. Wali holds Massachusetts license 295408.

Dr. Wali's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.

Dr. Wali's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Wali is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Wali to 4 more hospitals, 3 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wali practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wali's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Wali is licensed in Massachusetts.

CMS data shows 1,214 Medicare services from Dr. Wali across 5 procedure codes in 2024, for 342 Medicare patients. Medicare paid $124,154 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 342 Medicare patients who saw Dr. Wali in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 3.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wali's median patient age at 68, with 39% women.

In 2024, Dr. Wali wrote 2,215 Medicare Part D claims for 133 patients. 91% of them were for generic drugs. CMS names the drug for 1,874 of them, across 44 drugs with 11 or more claims each, at $110,262 in total drug cost. In 2023, CMS named 810 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wali for performance year 2024, reported through an alternative payment model (APM). Dr. Wali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Wali, published from 2010 to 2018. The most frequent topics are Graft Survival and Kidney Transplantation. Dr. Wali's most frequent co-authors are Sujata H. Ambardar, MD, Stephen T. Bartlett, MD and Tomas Berl, MD.

Dmand AI links Dr. Wali to 1 clinical trial. Conditions studied include Influenza, Human and Orthomyxoviridae Infections.

CMS Open Payments shows 16 general payments to Dr. Wali from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 66% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $108.